RP
Rapid Micro Biosystems, Inc.
RPID · NASDAQ
$1.11 -4.31% (-$0.05)
1M -28.85%
Market Cap $50.3M
P/E Ratio -
Div. Yield -
ROE 177.04%
Bulios Fair Price
$1.64
47.7% upside
Trenutna cena
$1.11
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RPID trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
81 /100
Cheap P/S 1.43x
P/B 2.83x
P/E N/A
Growth
78 /100
Growing Rev. growth 25.15%
Book val. growth 41.30%
EPS growth N/A
Profitability
1 /100
Weak Gross margin 10.03%
FCF margin 114.83%
Net margin 145.56%
Quality
8 /100
Poor ROIC 119.67%
Asset turnover 0.60x
ROE 177.04%
Debt
42 /100
Moderate Debt/Equity 1.32x
Int. coverage -19.36x
Current ratio 2.55x
Stability
71 /100
Stable Beta 1.44x
Profitable years 0
Rev. volatility 5.88%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RPID
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert G. Spignesi Jr.
Employees
171
Headquarters
Lexington
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report